Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator–activated receptor signaling pathway activation
Journal of Thrombosis and Haemostasis · 2026-08 · 24 (8) · 2801-2813
DOI: 10.1016/j.jtha.2026.04.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-08. Verfasst von Yu Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin H…. Hauptthemen laut MEDLINE: Metformin, Hemophilia A, Pioglitazone, PPAR gamma. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Double First Class University Plan, National Natural Science Foundation of China, Overseas Expertise Introduction Project for Discipline Innovation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, C…
- Research Center for Experimental Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Förderung
- Double First Class University Plan
- National Natural Science Foundation of China
- Overseas Expertise Introduction Project for Discipline Innovation
- Shanghai Municipal Health Commission
- Ministry of Education of the People's Republic of China
Zitieren
APA
Zhou, Y., Shen, Y., Yao, S. X., Wang, D. W., Chen, Z., & Chen, S. J. (2026). Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator–activated receptor signaling pathway activation. Journal of Thrombosis and Haemostasis, 24(8), 2801-2813. https://doi.org/10.1016/j.jtha.2026.04.032
Vancouver
Zhou Y, Shen Y, Yao SX, Wang DW, Chen Z, Chen SJ. Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator–activated receptor signaling pathway activation. Journal of Thrombosis and Haemostasis. 2026;24(8):2801-2813. doi:10.1016/j.jtha.2026.04.032
BibTeX
@article{Zhou2026,
author = {Zhou, Yu and Shen, Yan and Yao, Shu-Xian and Wang, Da-Wei and Chen, Zhu and Chen, Sai-Juan},
title = {Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator–activated receptor signaling pathway activation},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {8},
pages = {2801--2813},
doi = {10.1016/j.jtha.2026.04.032}
}
EUVIMED